Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Correlates of HBV-Specific B Cell Memory Following Vaccination in HIV-Infected and HIV-Uninfected Adolescents
NCT00142753Phase 4Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Aug 2005
- Primary completion
- Nov 2007
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4 trial of hepatitis B vaccine recombinant, hepatitis b vaccine recombinant and Recombivax HB in hepatitis B (HBV) (5 arms), sponsored by University of North Carolina at Chapel Hill. Primary endpoints: Interferon-γ (IFN-γ), interleukin-4 (IL-4), and interleukin-10 (IL-10) production, Concentration of hepatitis B antibodies and 1 more. Started Aug 2005; status: completed.
02
Drugs
hepatitis B vaccine recombinanthepatitis b vaccine recombinantRecombivax HB
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT00142753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00142753.